These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8732695)

  • 1. Treatment of oral cavity and oropharynx squamous cell carcinoma with perilymphatic interleukin-2: clinical and pathologic correlations.
    De Stefani A; Valente G; Forni G; Lerda W; Ragona R; Cortesina G
    J Immunother Emphasis Tumor Immunol; 1996 Mar; 19(2):125-33. PubMed ID: 8732695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infiltrating leukocyte populations and T-lymphocyte subsets in head and neck squamous cell carcinomas from patients receiving perilymphatic injections of recombinant interleukin 2. A pathologic and immunophenotypic study.
    Valente G; De Stefani A; Jemma C; Giovarelli M; Geuna M; Cortesina G; Forni G; Palestro G
    Mod Pathol; 1990 Nov; 3(6):702-8. PubMed ID: 2263594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved survival with perilymphatic interleukin 2 in patients with resectable squamous cell carcinoma of the oral cavity and oropharynx.
    De Stefani A; Forni G; Ragona R; Cavallo G; Bussi M; Usai A; Badellino F; Cortesina G
    Cancer; 2002 Jul; 95(1):90-7. PubMed ID: 12115321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of preoperative local interleukin-2 (IL-2) injections in patients with head and neck squamous cell carcinoma. An immunological study.
    Cortesina G; De Stefani A; Galeazzi E; Bussi M; Giordano C; Cavallo GP; Jemma C; Vai S; Forni G; Valente G
    Acta Otolaryngol; 1991; 111(2):428-33. PubMed ID: 2068931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx.
    Glaser CM; Millesi W; Kornek GV; Lang S; Schüll B; Watzinger F; Selzer E; Lavey RS
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):705-15. PubMed ID: 11395239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative radiochemotherapy and radical surgery in comparison with radical surgery alone. A prospective, multicentric, randomized DOSAK study of advanced squamous cell carcinoma of the oral cavity and the oropharynx (a 3-year follow-up).
    Mohr C; Bohndorf W; Carstens J; Härle F; Hausamen JE; Hirche H; Kimmig H; Kutzner J; Mühling J; Reuther J
    Int J Oral Maxillofac Surg; 1994 Jun; 23(3):140-8. PubMed ID: 7930766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-2 mediated regulation of mitogen-activated T cell reactivity from different lymphoid sources in patients with squamous cell carcinoma of the oral cavity.
    Murali PS; Somasundaram R; Rao RS; Fakih AR; Gangal SG
    J Oral Pathol Med; 1989 Jul; 18(6):327-32. PubMed ID: 2810131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of squamous cell carcinoma of the oral cavity, oropharynx and hypopharynx--an analysis of 174 patients in south western Finland.
    Luukkaa M; Minn H; Aitasalo K; Kronqvist P; Kulmala J; Pyrhönen S; Grénman R
    Acta Oncol; 2003; 42(7):756-62. PubMed ID: 14690162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume.
    Bisdas S; Nguyen SA; Anand SK; Glavina G; Day T; Rumboldt Z
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1313-8. PubMed ID: 18963541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perilymphatic injections of recombinant interleukin-2 (rIL-2) partially correct the immunologic defects in patients with advanced head and neck squamous cell carcinoma.
    Melioli G; Margarino G; Scala M; Mereu P; Bertoglio S; Schenone G; Barbaresi M; Machí AM; Santi L; Badellino F
    Laryngoscope; 1992 May; 102(5):572-8. PubMed ID: 1533435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined modality treatment of advanced cancers of the oral cavity and oropharynx.
    Dobrowsky W; Dobrowsky E; Strassl H; Braun O; Gritzmann N; Scheiber V
    Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):239-42. PubMed ID: 1899411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimodal intensification therapy for previously untreated advanced resectable squamous cell carcinoma of the oral cavity, oropharynx, or hypopharynx.
    Schuller DE; Grecula JC; Agrawal A; Rhoades CA; Orr DA; Young DC; Malone JP; Merz M
    Cancer; 2002 Jun; 94(12):3169-78. PubMed ID: 12115349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of posttreament significant body weight loss and its correlation with disease-free survival in patients with oral squamous cell carcinomas.
    Cho YW; Roh JL; Jung JH; Kim SB; Lee SW; Choi SH; Nam SY; Kim SY; Kim SY
    Nutr Cancer; 2013; 65(3):417-23. PubMed ID: 23530641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contralateral neck recurrence of squamous cell carcinoma of oral cavity and oropharynx.
    Chow TL; Chow TK; Chan TT; Yu NF; Fung SC; Lam SH
    J Oral Maxillofac Surg; 2004 Oct; 62(10):1225-8. PubMed ID: 15452809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of p27 expression in carcinoma of the oral cavity and oropharynx.
    Venkatesan TK; Kuropkat C; Caldarelli DD; Panje WR; Hutchinson JC; Chen S; Coon JS
    Laryngoscope; 1999 Aug; 109(8):1329-33. PubMed ID: 10443844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Postoperative Radiotherapy With Survival in Patients With N1 Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.
    Chen MM; Harris JP; Hara W; Sirjani D; Divi V
    JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1224-1230. PubMed ID: 27832255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx. Results of a multicentric double-blind randomised study.
    Bolla M; Lefur R; Ton Van J; Domenge C; Badet JM; Koskas Y; Laplanche A
    Eur J Cancer; 1994; 30A(6):767-72. PubMed ID: 7917535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on squamous carcinoma of the oral cavity, oropharynx, and maxillary sinus.
    Lubek JE; Clayman L
    Oral Maxillofac Surg Clin North Am; 2012 May; 24(2):307-16, x. PubMed ID: 22341511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local/regional recombinant interleukin 2 (rIL-2) immunotherapy of tumors. Intra-arterial continuous infusion of rIL-2 in bladder cancer patients: a phase I study.
    Velotti F; Tubaro A; Stoppacciaro A; Pettinato A; Morrone S; Bossola P; Napolitano T; Miano L; Ruco L; Piccoli M
    Ann Ist Super Sanita; 1990; 26(3-4):411-21. PubMed ID: 2091503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squamous cell carcinoma of the oral cavity and oropharynx in young adults.
    Cusumano RJ; Persky MS
    Head Neck Surg; 1988; 10(4):229-34. PubMed ID: 3235353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.